Literature DB >> 33131070

Novel insight from the first lung transplant of a COVID-19 patient.

Xiao-Jun Chen1, Kai Li2, Lei Xu1, You-Jia Yu2, Bo Wu3, Yuan-Lin He4, Wen-E Zhao5, Ding Li2, Chang-Xing Luan2, Li Hu2, Jie Wang2, Jing-Jing Ding2, Yan-Fang Yu2, Jing-Xin Li6, Zhong-Ming Tan6, Xiao-Fei Liu4, Dong Wei3, Zhi-Hong Zhang7, Xue-Jiang Guo4, Chuan Su1, Zhi-Bin Hu4,8, Yue-Shuai Guo4, Jing-Yu Chen3, Feng Chen2,9.   

Abstract

BACKGROUND: To reveal detailed histopathological changes, virus distributions, immunologic properties and multi-omic features caused by SARS-CoV-2 in the explanted lungs from the world's first successful lung transplantation of a COVID-19 patient.
MATERIALS AND METHODS: A total of 36 samples were collected from the lungs. Histopathological features and virus distribution were observed by optical microscope and transmission electron microscope (TEM). Immune cells were detected by flow cytometry and immunohistochemistry. Transcriptome and proteome approaches were used to investigate main biological processes involved in COVID-19-associated pulmonary fibrosis.
RESULTS: The histopathological changes of the lung tissues were characterized by extensive pulmonary interstitial fibrosis and haemorrhage. Viral particles were observed in the cytoplasm of macrophages. CD3+ CD4- T cells, neutrophils, NK cells, γ/δ T cells and monocytes, but not B cells, were abundant in the lungs. Higher levels of proinflammatory cytokines iNOS, IL-1β and IL-6 were in the area of mild fibrosis. Multi-omics analyses revealed a total of 126 out of 20,356 significant different transcription and 114 out of 8,493 protein expression in lung samples with mild and severe fibrosis, most of which were related to fibrosis and inflammation.
CONCLUSIONS: Our results provide novel insight that the significant neutrophil/ CD3+ CD4- T cell/ macrophage activation leads to cytokine storm and severe fibrosis in the lungs of COVID-19 patient and may contribute to a better understanding of COVID-19 pathogenesis.
© 2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; inflammation; lung transplantation; pathology

Mesh:

Substances:

Year:  2020        PMID: 33131070     DOI: 10.1111/eci.13443

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

Review 1.  Alveolar type II cells and pulmonary surfactant in COVID-19 era.

Authors:  A Calkovska; M Kolomaznik; V Calkovsky
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.

Authors:  Resat Cinar; Malliga R Iyer; George Kunos
Journal:  Br J Pharmacol       Date:  2021-04-17       Impact factor: 9.473

Review 3.  How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.

Authors:  Jonathan Caron; Laura Alice Ridgley; Mark Bodman-Smith
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

Review 4.  Multiomics integration-based molecular characterizations of COVID-19.

Authors:  Chuan-Xing Li; Jing Gao; Zicheng Zhang; Lu Chen; Xun Li; Meng Zhou; Åsa M Wheelock
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

5.  Clinical, radiological, and transbronchial biopsy findings in patients with long COVID-19: a case series.

Authors:  Bruno Guedes Baldi; Alexandre Todorovic Fabro; Andreia Craveiro Franco; Marília Helena C Machado; Robson Aparecido Prudente; Estefânia Thomé Franco; Sergio Ribeiro Marrone; Simone Alves do Vale; Talita Jacon Cezare; Marcelo Padovani de Toledo Moraes; Eloara Vieira Machado Ferreira; André Luis Pereira Albuquerque; Marcio Valente Yamada Sawamura; Suzana Erico Tanni
Journal:  J Bras Pneumol       Date:  2022-04-29       Impact factor: 2.800

6.  SARS-CoV-2 spike and nucleocapsid proteins fail to activate human dendritic cells or γδ T cells.

Authors:  Kiran Singh; Sita Cogan; Stefan Elekes; Dearbhla M Murphy; Sinead Cummins; Rory Curran; Zaneta Najda; Margaret R Dunne; Gráinne Jameson; Siobhan Gargan; Seamus Martin; Aideen Long; Derek G Doherty
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

7.  Lung Transplantation in Patients With COVID-19-The Early National Experience.

Authors:  Isabella S Florissi; Eric W Etchill; Iulia Barbur; Katherine G Verdi; Christian Merlo; Errol L Bush
Journal:  Semin Thorac Cardiovasc Surg       Date:  2022-08-28

Review 8.  Defying convention in the time of COVID-19: Insights into the role of γδ T cells.

Authors:  Marta Sanz; Brendan T Mann; Alisha Chitrakar; Natalia Soriano-Sarabia
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

Review 9.  [Pericarditis is inflammation of the pericardium, which rheumatologists should know].

Authors:  M Krusche; U Schneider; N Ruffer
Journal:  Z Rheumatol       Date:  2020-11-20       Impact factor: 1.372

10.  Reversibility of total airway closure and alveolar consolidation in a COVID-19 patient: A case study.

Authors:  Sebastian Voicu; Alexandre Brudon; Louis Modestin; Kiyoko Nitenberg; Antoine Gonde; Isabelle Malissin; Bruno Mégarbane
Journal:  Nurs Crit Care       Date:  2021-07-29       Impact factor: 2.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.